Creative Biolabs Integrates Custom Oligosaccharide Synthesis with Glycan Characterization to Advance Drug Discovery

Creative Biolabs has announced an integrated approach to custom oligosaccharide synthesis and glycan characterization, aiming to support researchers in drug discovery, vaccine development, and biomarker studies. The company combines chemical, enzymatic, and chemoenzymatic synthesis technologies with analytical platforms including mass spectrometry (MS), high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR) to deliver structurally validated glycans.

Oligosaccharides play critical roles in cell signaling, immune regulation, and disease progression, making them valuable for therapeutic and diagnostic applications. However, their structural complexity poses challenges in synthesis, purification, and characterization. Creative Biolabs addresses these issues by offering custom synthesis of high-purity oligosaccharides, complex glycans, tumor-associated carbohydrate antigens (TACAs), and functionalized derivatives, alongside rigorous analytical validation.

“The structural complexity of oligosaccharides continues to present significant challenges for researchers developing next-generation therapeutics,” said a scientist from Creative Biolabs. “By integrating custom synthesis with comprehensive analytical characterization, we help researchers obtain structurally validated glycans that support reliable downstream studies and accelerate scientific discovery.”

In a recent project, researchers required a complex glycan structure not readily available from commercial sources. The integrated synthesis and analytical characterization services facilitated structural confirmation and supported downstream applications. Creative Biolabs’ portfolio includes custom oligosaccharide synthesis, advanced glycan characterization, and application-oriented carbohydrate design for structural biology, glycoprotein research, biomarker discovery, immunology, and targeted drug delivery.

By combining synthesis and characterization under one platform, the company helps reduce technical risks, improve experimental reproducibility, and support efficient project progression. Researchers can explore customized options through Creative Biolabs' glycobiology platform at https://www.creative-biolabs.com/glycoprotein/.